Related Experiment Video

Updated: Jun 17, 2026

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

[Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and single-pill

Takafumi Okura1, Jitsuo Higaki

  • 1Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Japan.

Clinical Calcium
|January 6, 2010
PubMed

Insights

Calcium channel blockers (CCB) and angiotensin receptor blockers (ARB) are key hypertension drugs. Single-pill combinations with statins are crucial for managing hypertension and preventing atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Calcium channel blockers (CCB) and angiotensin receptor antagonists (ARB) are first-line treatments for hypertension in Japan.
  • Monotherapy with CCB or ARB is often insufficient for adequate blood pressure control.
  • Hypertension frequently coexists with dyslipidemia, necessitating comprehensive treatment strategies.

Purpose:

  • To highlight the importance of combination therapy in managing hypertension.
  • To emphasize the role of single-pill combinations in treating hypertensive and dyslipidemic patients.
  • To discuss the therapeutic significance of combining CCB with ARB or statins.

Summary:

  • CCBs and ARBs are widely used antihypertensive drugs.
  • Combination therapy is often required for effective blood pressure management.
  • Single-pill formulations of CCB/ARB or CCB/statin offer a vital approach for hypertensive patients, particularly those with dyslipidemia, aiding in both blood pressure control and anti-atherosclerotic therapy.

Impact:

  • Single-pill combinations improve patient adherence and therapeutic outcomes.
  • This approach addresses the dual burden of hypertension and dyslipidemia, crucial for preventing cardiovascular events.
  • Facilitates integrated management of hypertension and atherosclerosis through convenient combination therapies.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...